story of the week
Neoadjuvant Chemotherapy With or Without Anthracyclines in the Presence of Dual HER2 Blockade for HER2-Positive Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Neoadjuvant Chemotherapy With or Without Anthracyclines in the Presence of Dual HER2 Blockade for HER2-Positive Breast Cancer (TRAIN-2): A Multicentre, Open-Label, Randomised, Phase 3 Trial
Lancet Oncol 2018 Nov 06;[EPub Ahead of Print], MS van Ramshorst, A van der Voort, ED van Werkhoven, IA Mandjes, I Kemper, VO Dezentjé, IM Oving, AH Honkoop, LW Tick, AJ van de Wouw, CM Mandigers, LJ van Warmerdam, J Wesseling, MT Vrancken Peeters, SC Linn, GS SonkeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.